Current sources establish Canadian legal and regulatory baselines for drug approvals, safety alerts, compliance, enforcement, recalls, and health-product information, but not Alberta independence transition terms.source supportedhigh risk
/ Claims and evidence
Would prescription drug approvals, recalls, and medicine supply still work?
Key claims used in this dossier, paired with the sources that support them. Claim status and risk labels come from the public claim ledger for this topic.
A credible transition would need explicit arrangements for recognizing approvals, labelling, recalls, adverse-event reporting, import rules, pharmacy guidance, manufacturer guidance, and supply continuity.inferencehigh risk
The pro-independence case is strongest if Alberta can preserve current medicine access through recognition and supply bridges before attempting local regulatory redesign.inferencehigh risk
The anti-independence caution is strongest because medicine safety requires trusted legal authority, regulator capacity, recall channels, and supply-chain clarity before patients can rely on continuity.inferencehigh risk